How Many mg Is 40 Units of Tirzepatide?
0.4 mL, always. What that draw is worth ranges from 1.332 mg to 24 mg depending on your concentration. Enter your own vial below.
Written by Kashif Khan, who builds and maintains this site and is not a clinician. Every figure links to its primary source.
Why there is no single answer
A syringe unit measures volume, not mass: one unit is 1/100 of a millilitre. So Tirzepatide at 40 mg lands on a different mark at every concentration. Find the row matching the vial and water volume you actually used.
40 units at every concentration
ISO 8537 fixes the U-100 scale, so 100 units is 1 mL on every insulin syringe sold for human use and the conversion is a division rather than a lookup. The divisor is your concentration. Each row below is a vial you might plausibly be holding rather than an abstract mg/mL figure, because nobody owns “12.5 mg/mL” — they own a 25 mg vial and a syringe of water.
| Concentration | A vial that gives it | Dose in that draw | On an approved label? |
|---|---|---|---|
| 3.33 mg/mL | 10 mg vial + 3 mL | 1.332 mg | No approved schedule uses this figure |
| 5 mg/mL | 10 mg vial + 2 mL | 2 mg | No approved schedule uses this figure |
| 6.67 mg/mL | 20 mg vial + 3 mL | 2.668 mg | No approved schedule uses this figure |
| 10 mg/mL | 10 mg vial + 1 mL | 4 mg | No approved schedule uses this figure |
| 13.33 mg/mL | 40 mg vial + 3 mL | 5.332 mg | No approved schedule uses this figure |
| 15 mg/mL | 30 mg vial + 2 mL | 6 mg | No approved schedule uses this figure |
| 20 mg/mL | 20 mg vial + 1 mL | 8 mg | No approved schedule uses this figure |
| 30 mg/mL | 30 mg vial + 1 mL | 12 mg | No approved schedule uses this figure |
| 40 mg/mL | 40 mg vial + 1 mL | 16 mg | No approved schedule uses this figure |
| 60 mg/mL | 60 mg vial + 1 mL | 24 mg | No approved schedule uses this figure |
The volume is fixed across that table at 0.4 mL and the dose moves, by a factor of twelve from top to bottom. The plunger stops in exactly the same place in every row. Nothing visible on the syringe distinguishes them, which is why the concentration has to be written on the vial rather than remembered.
What 40 units is worth against an approved dose
The column above matches each delivered dose against the FDA titration schedules this site reproduces. A match means the arithmetic happens to land on a labelled step, not that the step applies to you — those schedules also specify a starting dose, a minimum interval between increases and a maximum, none of which a syringe can enforce. At 40 mg/mL, 60 mg/mL this draw delivers more than the highest dose on any approved schedule here (15 mg).
Making 40 units deliver a labelled dose
The table above holds the vial fixed and asks what the mark is worth. This one holds the mark fixed at 40 units and asks the practical question: for 40 units to deliver each dose that actually appears on an approved schedule, what concentration does the vial have to be, and which vial-and-water pairing gets there with a volume of water you can measure?
| Labelled dose | On the schedule for | Vial must be | A vial that gives it |
|---|---|---|---|
| 2.5 mg | Zepbound | 6.25 mg/mL | 10 mg + 1.6 mL |
| 5 mg | Zepbound | 12.5 mg/mL | 10 mg + 0.8 mL · 20 mg + 1.6 mL · 30 mg + 2.4 mL |
| 7.5 mg | Zepbound | 18.75 mg/mL | 10 mg + 0.53 mL · 20 mg + 1.07 mL · 30 mg + 1.6 mL · 40 mg + 2.13 mL |
| 10 mg | Zepbound | 25 mg/mL | 20 mg + 0.8 mL · 30 mg + 1.2 mL · 40 mg + 1.6 mL · 60 mg + 2.4 mL |
| 12.5 mg | Zepbound | 31.25 mg/mL | 20 mg + 0.64 mL · 30 mg + 0.96 mL · 40 mg + 1.28 mL · 60 mg + 1.92 mL |
| 15 mg | Zepbound | 37.5 mg/mL | 20 mg + 0.53 mL · 30 mg + 0.8 mL · 40 mg + 1.07 mL · 60 mg + 1.6 mL |
The pattern to notice is how quickly the required concentration climbs as the dose does: the same 40 units has to be 6 times stronger to deliver the top of the table than the bottom. That is why one water volume cannot serve a whole titration — a vial mixed so that 40 units is the starting dose reads far past the barrel by the time the schedule reaches its maximum. A dose that appears on a schedule is not thereby yours; the schedule also fixes a start, an interval and a ceiling, and this table respects none of them.
What the Tirzepatide label actually says
Approved 13 May 2022 as Mounjaro for type 2 diabetes, and 8 November 2023 as Zepbound for chronic weight management; Zepbound added obstructive sleep apnea on 20 December 2024. Every approved presentation is a ready-to-use sterile solution — no FDA-approved tirzepatide product is a lyophilised powder requiring reconstitution. Powder vials come from compounders, and the FDA declared the tirzepatide shortage resolved on 19 December 2024, ending the shortage basis for compounding it.
That matters here because the approved schedule is a fixed ladder, and the conversion above does not know where on it you are. The dosage may be increased in 2.5 mg increments after at least 4 weeks on the current dose. The label is explicit that the 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage. The maximum is 15 mg once weekly.
- 2.5 mg — starting dose, at least 4 weeks
- 5 mg — valid maintenance dose for weight reduction, at least 4 weeks
- 7.5 mg — titration step, at least 4 weeks
- 10 mg — maintenance; minimum maintenance dose for sleep apnea, at least 4 weeks
- 12.5 mg — titration step, at least 4 weeks
- 15 mg — maximum recommended dose
Full sourcing, the reconstitution calculator and the published evidence are on the Tirzepatide page.
Which barrel actually holds 40 units
U-100 syringes come in four common barrels. They share a scale, so 40 units is 0.4 mL in all of them — but they differ in capacity and in how finely they are printed, and those two things decide whether the draw is a measurement or an estimate.
| Barrel | Capacity | Printed steps | 40 units on it |
|---|---|---|---|
| 0.3 mL "30 unit" (U-100) | 30 units | 1 | Does not fit — more than the barrel holds |
| 0.3 mL half-unit (U-100) | 30 units | 0.5 | Does not fit — more than the barrel holds |
| 0.5 mL "50 unit" (U-100) | 50 units | 1 | Fills it 80% to a printed mark |
| 1 mL "100 unit" (U-100) | 100 units | 2 | Fills it 40% to a printed mark |
The smallest barrel that both holds 40 units and puts it on a printed mark is the 0.5 mL "50 unit" (U-100), where it fills 80% of the barrel. A draw using a good fraction of the barrel is the accurate case; the published low-dose accuracy work finds error concentrating in draws that barely leave the bottom of the syringe.
Working it out yourself
Divide the milligrams of peptide in the vial by the millilitres of water you added. That is your concentration in mg/mL. Then divide 40 by 100 to turn units into millilitres — 0.4 mL — and multiply by the concentration to get the dose. Worked through at 10 mg/mL: 0.4 × 10 = 4 mg. Two figures, one division, one multiplication. Every calculator doing this — including this one — is doing nothing more than that.
One honest caveat about the first step: the lyophilised cake occupies volume of its own, so the finished solution is marginally more than the water you added and the true concentration marginally lower than the division suggests. Measured displacement for lyophilised powders runs about 0.66 to 0.70 mL per gram of total solids, so a milligram-scale peptide vial displaces a few microlitres — well under one unit on a U-100 barrel, and finer than the barrel can be read. FDA labels state the nominal concentration without correcting for it either. The exception is a vial carrying a heavy bulking agent, where displacement can reach several percent.
For a fuller picture including the approved dosing schedule and its sources, see the Tirzepatide calculator.
Where this particular conversion goes wrong
- The syringe is not U-100. A U-40 veterinary barrel is fixed at 40 units per mL by 21 CFR 522.1160 and is still sold for animal insulin, which is labelled at that strength. 40 units holds 0.4 mL on a U-100 barrel and 1 mL on a U-40 one. Two and a half times the volume, from a barrel that looks the same. Both over- and under-dosing from exactly this substitution are documented in the published case literature.
- Reaching for the 0.3 mL barrel out of habit. It holds 30 units, and 40 is more than that. The barrels people keep in the same drawer are not interchangeable by capacity, and a draw that runs out of barrel halfway is the point at which doses get split, guessed or abandoned. The 0.5 mL "50 unit" (U-100) is the one that holds this.
- One mark either way. On a 0.3 or 0.5 mL barrel one mark is 1 unit, so a one-mark slip at 40 units is a 3% error in the dose at any concentration. On a 1 mL barrel printed in 2-unit steps the same slip is 5%. The percentage is fixed by the mark, not the drug: it is the reason a small draw belongs on a small barrel.
- Reading "40 units" as a dose. It is a volume, and it is the same volume in every vial you will ever fill to that mark. The dose it carries is set entirely by what is dissolved in it — 1.332 mg to 24 mg across the table above.
- Assuming the vial holds what the label says. Every figure here starts from the milligrams stated on your vial. For an FDA-approved product that figure is verified; for a compounded or grey-market vial nobody has checked it, and no calculator can. The arithmetic is exact — its input may not be.
Common questions
Sources
Every number on this page comes from one of the documents below. Where no reliable source exists, the page says so instead of filling the gap.
- FDA labelFDA / DailyMed· 2026-08MOUNJARO (tirzepatide) injection — FDA prescribing information
- FDA labelFDA / DailyMed· 2026-08ZEPBOUND (tirzepatide) injection — FDA prescribing information
- Published studyNew England Journal of Medicine· 2025Aronne LJ et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5)
- GuidelineInternational Organization for Standardization· 2016-03ISO 8537:2016 — Sterile single-use syringes, with or without needle, for insulin (scope and requirements; full text not public)
- RegulatorFDA / Federal Register· 1998-05-13Removal of Regulations Regarding Certification of Drugs Composed Wholly or Partly of Insulin — 63 FR 26694 (the repealed insulin colour scheme, and U-40 no longer marketed)
- RegulatorUS Code of Federal Regulations / FDA21 CFR 522.1160 — Insulin (animal drugs): 40 international units (IU) per millilitre
- Published studyCase Reports in Endocrinology 2019;2019:7916435· 2019Barrera F, Murvelashvili N. Poorly controlled type 3c diabetes due to use of veterinarian insulin syringes
- Published studyDiabetology International 2024;15(3):544–549· 2024-05Kondo M, Saji R, Yamada Y, et al. Analysis of factors affecting the accuracy of low-dose insulin dosage using syringes and vials
- Published studyClinical Pediatrics 2004;43(1):69–74· 2004-01Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump
- Published studyBMJ Paediatrics Open· 2023Zheng L-Y et al. Displacement volume of reconstituted powder injections and its effect on dosing accuracy